110 CONTINUED VERSUS INTERRUPTED ASPIRIN USE AND BLEEDING RISK AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION OF GASTRIC NEOPLASMS: A META-ANALYSIS

Balancing the risk of bleeding and thromboembolic events for patients who use aspirin and need to undergo endoscopic submucosal dissection (ESD) for gastric neoplasms is a delicate process. The current guidelines from different associations provide inconsistent recommendations. For instance, the American Society of Gastrointestinal Endoscopy recommends continuing aspirin peri-procedurally regardless of thrombotic risks, whereas the European Society of Gastrointestinal Endoscopy recommends that aspirin discontinuation should be considered for patients whose risk of hemorrhage outweighs the risk of thrombotic events.

https://ift.tt/2xnft76